Control of topoisomerase II activity and chemotherapeutic inhibition by TCA cycle metabolites

Almeida, 2010, E3 ubiquitin ligase APC/C-Cdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation, Proc. Natl. Acad. Sci. U S A, 107, 738, 10.1073/pnas.0913668107 Anand, 2017, Cas9-mediated gene editing in Saccharomyces cerevisiae, Protoc. Exch., 1 Astuti, 2001, Gene mutations in succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial parnganglioma, Am. J. Hum. Genet., 69, 49, 10.1086/321282 Azarova, 2007, Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies, Proc. Natl. Acad. Sci. U S A, 104, 11014, 10.1073/pnas.0704002104 Baksh, 2020, Metabolic coordination of cell fate by α-ketoglutarate-dependent dioxygenases, Trends Cell Biol., 31, 24, 10.1016/j.tcb.2020.09.010 Balss, 2008, Analysis of the IDH1 codon 132 mutation in brain tumors, Acta Neuropathol., 116, 597, 10.1007/s00401-008-0455-2 Barrington, 2017, Chromosome structure dynamics during the cell cycle: a structure to fit every phase, EMBO J., 36, 2661, 10.15252/embj.201798014 Bauer, 2012, DNA catenation maintains structure of human metaphase chromosomes, Nucleic Acids Res., 40, 11428, 10.1093/nar/gks931 Baysal, 2000, Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma, Science, 287, 848, 10.1126/science.287.5454.848 Boer, 2010, Growth-limiting intracellular metabolites in yeast growing under diverse nutrient limitations, Mol. Biol. Cell, 21, 198, 10.1091/mbc.e09-07-0597 Borger, 2012, Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping, Oncologist, 17, 72, 10.1634/theoncologist.2011-0386 Brauer, 2008, Coordination of growth rate, cell cycle, stress response, and metabolic activity in yeast, Mol. Biol. Cell, 19, 352, 10.1091/mbc.e07-08-0779 Buchakjian, 2010, The engine driving the ship: metabolic steering of cell proliferation and death, Nat. Rev. Mol. Cell Biol., 11, 715, 10.1038/nrm2972 Cai, 2020, Phosphorylation of PDHA by AMPK drives TCA cycle to promote cancer metastasis, Mol. Cell, 80, 263, 10.1016/j.molcel.2020.09.018 Cavalli, 1997, Diminished tumorigenic phenotype after depletion of mitochondrial DNA, Cell Growth Differ., 8, 1189 Charbin, 2014, Condensin aids sister chromatid decatenation by topoisomerase II, Nucleic Acids Res., 42, 340, 10.1093/nar/gkt882 Colombo, 2010, Anaphase-promoting complex/cyclosome-Cdh1 coordinates glycolysis and glutaminolysis with transition to S phase in human T lymphocytes, Proc. Natl. Acad. Sci. U S A, 107, 18868, 10.1073/pnas.1012362107 Corbett, 2005, The structural basis for substrate specificity in DNA topoisomerase IV, J Mol Biol, 351, 545, 10.1016/j.jmb.2005.06.029 Crabtree, 1928, The carbohydrate metabolism of certain pathological overgrowths, Biochem. J., 22, 1289, 10.1042/bj0221289 Crutchfield, 2010 Cuvier, 2003, A role of topoisomerase II in linking DNA replication to chromosome condensation, J. Cell Biol., 160, 645, 10.1083/jcb.200209023 Daniloski, 2019, Resolution of human ribosomal DNA occurs in anaphase, dependent on tankyrase 1, condensin II, and topoisomerase IIα, Genes Dev., 33, 276, 10.1101/gad.321836.118 Diaz-Moralli, 2013, Targeting cell cycle regulation in cancer therapy, Pharmacol. Ther., 138, 255, 10.1016/j.pharmthera.2013.01.011 Diaz-Ruiz, 2011, The Warburg and Crabtree effects: on the origin of cancer cell energy metabolism and of yeast glucose repression, Biochim. Biophys. Acta, 1807, 568, 10.1016/j.bbabio.2010.08.010 Driever, 1988, A gradient of bicoid protein in Drosophila embryos, Cell, 54, 83, 10.1016/0092-8674(88)90182-1 Eser, 2011, Commitment to a cellular transition precedes genome-wide transcriptional change, Mol. Cell, 43, 515, 10.1016/j.molcel.2011.06.024 Felix, 1998, Secondary leukemias induced by topoisomerase-targeted drugs, Biochim. Biophys. Acta, 1400, 233, 10.1016/S0167-4781(98)00139-0 Fradin, 2017, On the importance of protein diffusion in biological systems: the example of the bicoid morphogen gradient, Biochim. Biophys. Acta, 1865, 1676, 10.1016/j.bbapap.2017.09.002 Goto, 1984, Yeast DNA topoisomerase II is encoded by a single-copy, essential gene, Cell, 36, 1073, 10.1016/0092-8674(84)90057-6 Güldener, 1996, A new efficient gene disruption cassette for repeated use in budding yeast, Nucleic Acids Res., 24, 2519, 10.1093/nar/24.13.2519 Guppy, 2002, Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells, Biochem. J., 364, 309, 10.1042/bj3640309 Heck, 1988, Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle, Proc. Natl. Acad. Sci. U S A, 85, 1086, 10.1073/pnas.85.4.1086 Herzig, 2012, Identification and functional expression of the mitochondrial pyruvate carrier, Science, 336, 93, 10.1126/science.1218530 Intlekofer, 2019, Metabolic signatures of cancer cells and stem cells, Nat. Metab., 1, 177, 10.1038/s42255-019-0032-0 Ishida, 1995, DNA topoisomerase II is the molecular target of bisdioxopiperazine derivatives ICRF-159 and ICRF-193 in Saccharomyces cerevisiae, Cancer Res., 55, 2299 Janeway, 2011, Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations, Proc. Natl. Acad. Sci. U S A, 108, 314, 10.1073/pnas.1009199108 Johnson, 1965, Ribonucleic acid and protein synthesis in mitotic HeLa cells, J. Cell Biol., 27, 565, 10.1083/jcb.27.3.565 Kimura, 1994, Growth state- and cell cycle-dependent fluctuation in the expression of two forms of DNA topoisomerase II and possible specific modification of the higher molecular weight form in the M phase, J. Biol. Chem., 269, 1173, 10.1016/S0021-9258(17)42238-1 King, 2006, Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer, Oncogene, 25, 4675, 10.1038/sj.onc.1209594 Konokhova, 2016, Failed upregulation of TFAM protein and mitochondrial DNA in oxidatively deficient fibers of chronic obstructive pulmonary disease locomotor muscle, Skelet. Muscle, 6, 1, 10.1186/s13395-016-0083-9 Lebleu, 2014, PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis, Nat. Cell Biol., 16, 992, 10.1038/ncb3039 Lee, 2013, Metabolic regulation of the cell cycle, Curr. Opin. Cell Biol., 25, 724, 10.1016/j.ceb.2013.07.002 Lee, 2019, Cell cycle-dependent control and roles of DNA topoisomerase II, Genes (Basel), 10, 859, 10.3390/genes10110859 Lee, 2017, Resveratrol: a novel type of topoisomerase II inhibitor, J. Biol. Chem., 292, 21011, 10.1074/jbc.M117.810580 Letouzé, 2013, SDH mutations establish a hypermethylator phenotype in paraganglioma, Cancer Cell, 23, 739, 10.1016/j.ccr.2013.04.018 Li, 2014, Direct visualization of de novo lipogenesis in single living cells, Sci. Rep., 4, 1 Littau, 1964, Active and inactive regions of nuclear chromatin as revealed by electron microscope autoradiography, Proc. Natl. Acad. Sci., 52, 93, 10.1073/pnas.52.1.93 Liu, 2021, Skp2 dictates cell cycle-dependent metabolic oscillation between glycolysis and TCA cycle, Cell Res., 31, 80, 10.1038/s41422-020-0372-z Locasale, 2011, Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis, Nat. Genet., 43, 869, 10.1038/ng.890 Lucas, 2001, Topoisomerase II can unlink replicating DNA by precatenane removal, EMBO J., 20, 6509, 10.1093/emboj/20.22.6509 Martin, 1998, Energetic and morphological plasticity of C6 glioma cells grown on 3-D support; effect of transient glutamine deprivation, J. Bioenerg. Biomembr., 30, 565, 10.1023/A:1020584517588 McFaline-Figueroa, 2015, Minor changes in expression of the mismatch repair protein MSH2 exert a major impact on glioblastoma response to temozolomide, Cancer Res., 75, 3127, 10.1158/0008-5472.CAN-14-3616 Menendez, 2007, Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis, Nat. Rev. Cancer, 7, 763, 10.1038/nrc2222 Morais, 1994, Tumor-forming ability in athymic nude mice of human cell lines devoid of mitochondrial DNA, Cancer Res., 54, 3889 Morita, 2019, Repression of mitochondrial metabolism for cytosolic pyruvate-derived chemical production in Saccharomyces cerevisiae, Microb. Cell Fact., 18, 1, 10.1186/s12934-019-1226-6 Nitiss, 2009, Targeting DNA topoisomerase II in cancer chemotherapy, Nat. Rev. Cancer, 9, 338, 10.1038/nrc2607 Nitiss, 1992, Amsacrine and etoposide hypersensitivity of yeast cells overexpressing DNA topoisomerase II, Cancer Res., 52, 4467 Osheroff, 1987, Role of the divalent cation in topoisomerase II mediated reactions, Biochemistry, 26, 6402, 10.1021/bi00394a015 Park, 2016, Metabolite concentrations, fluxes and free energies imply efficient enzyme usage, Nat. Chem. Biol., 12, 482, 10.1038/nchembio.2077 Pasdois, 2003, Contribution of the phosphorylable complex I in the growth phase-dependent respiration of C6 glioma cells in vitro, J. Bioenerg. Biomembr., 35, 439, 10.1023/A:1027391831382 Pavlova, 2016, The emerging hallmarks of cancer metabolism, Cell Metab., 23, 27, 10.1016/j.cmet.2015.12.006 Peter, 1998, The structure of supercoiled intermediates in DNA replication, Cell, 94, 819, 10.1016/S0092-8674(00)81740-7 Pommier, 1989, Topological complexes between DNA and topoisomerase II and effects of polyamines, Biochemistry, 28, 995, 10.1021/bi00429a012 Pommier, 2010, DNA topoisomerases and their poisoning by anticancer and antibacterial drugs, Chem. Biol., 17, 421, 10.1016/j.chembiol.2010.04.012 Postow, 2001, Topological challenges to DNA replication: conformations at the fork, Proc. Natl. Acad. Sci. U S A, 98, 8219, 10.1073/pnas.111006998 Prescott, 1962, Synthesis of RNA and protein during mitosis in mammalian tissue culture cells, Exp. Cell Res., 26, 260, 10.1016/0014-4827(62)90176-3 Ross, 1984, Role of topoisomerase II in mediating epipodophyllotoxin-induced DMA cleavage 1, Cancer Res., 44, 5857 Salazar-Roa, 2017, Fueling the cell division cycle, Trends Cell Biol., 27, 69, 10.1016/j.tcb.2016.08.009 Samejima, 2012, Mitotic chromosomes are compacted laterally by KIF4 and condensin and axially by topoisomerase IIα, J. Cell Biol., 199, 755, 10.1083/jcb.201202155 Selak, 2005, Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase, Cancer Cell, 7, 77, 10.1016/j.ccr.2004.11.022 Spellman, 1998, Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization, Mol. Biol. Cell, 9, 3273, 10.1091/mbc.9.12.3273 Srivatsan, 2008, Control of bacterial transcription, translation and replication by (p)ppGpp, Curr. Opin. Microbiol., 11, 100, 10.1016/j.mib.2008.02.001 Srivenugopal, 1987, Aggregation of DNA by analogs of spermidine, enzymatic and structural studies, Nucleic Acids Res., 15, 2563, 10.1093/nar/15.6.2563 Stepanov, 2008, Enhancing drug accumulation in Saccharomyces cerevisiae by repression of pleiotropic drug resistance genes with chimeric transcription repressors, Mol. Pharmacol., 74, 423, 10.1124/mol.107.044651 Sud, 2016, Metabolomics Workbench: an international repository for metabolomics data and metadata, metabolite standards, protocols, tutorials and training, and analysis tools, Nucleic Acids Res., 44, D463, 10.1093/nar/gkv1042 Sulkowski, 2020 Sun, 2013, Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway, Science, 339, 786, 10.1126/science.1232458 Sundin, 1981, Arrest of segregation leads to accumulation of highly intertwined catenated dimers: dissection of the final stages of SV40 DNA replication, Cell, 25, 659, 10.1016/0092-8674(81)90173-2 Tan, 2015, Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA, Cell Metab., 21, 81, 10.1016/j.cmet.2014.12.003 Tanabe, 1991, Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives, Cancer Res., 51, 4903 Taylor, 1960, Nucleic acid synthesis in relation to the cell division cycle, Ann. N. Y. Acad. Sci., 90, 409, 10.1111/j.1749-6632.1960.tb23259.x Tomlinson, 2002, Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer the multiple leiomyoma consortium, Nat. Genet., 30, 406, 10.1038/ng849 Tudzarova, 2011, Two ubiquitin ligases, APC/C-Cdh1 and SKP1-CUL1-F (SCF)-β-TrCP, sequentially regulate glycolysis during the cell cycle, Proc. Natl. Acad. Sci. U S A, 108, 5278, 10.1073/pnas.1102247108 Turcotte, 2018, Risk, risk factors, and surveillance of subsequent malignant neoplasms in survivors of childhood cancer: a review, J. Clin. Oncol., 36, 2145, 10.1200/JCO.2017.76.7764 Uemura, 1987, DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe, Cell, 50, 917, 10.1016/0092-8674(87)90518-6 Da Veiga Moreira, 2015, Cell cycle progression is regulated by intertwined redox oscillators, Theor. Biol. Med. Model., 12, 1, 10.1186/s12976-015-0005-2 Vos, 2011, All tangled up: how cells direct, manage and exploit topoisomerase function, Nat. Rev. Mol. Cell Biol., 12, 827, 10.1038/nrm3228 Vos, 2013, Distinct regions of the Escherichia coli ParC C-terminal domain are required for substrate discrimination by topoisomerase IV, J. Mol. Biol., 425, 3029, 10.1016/j.jmb.2013.04.033 Walkiewicz, 2012, Small changes in enzyme function can lead to surprisingly large fitness effects during adaptive evolution of antibiotic resistance, Proc. Natl. Acad. Sci. U S A, 109, 21408, 10.1073/pnas.1209335110 Wang, 2014, Cyclin B1/Cdk1 coordinates mitochondrial respiration for cell-cycle G2/M progression, Dev. Cell, 29, 217, 10.1016/j.devcel.2014.03.012 Warburg, 1925, The metabolism of carcinoma cells, J. Cancer Res., 9, 148, 10.1158/jcr.1925.148 Wasserman, 1994, Mechanistic studies of amsacrine-resistant derivatives of DNA topoisomerase II. Implications in resistance to multiple antitumor drugs targeting the enzyme, J. Biol. Chem., 269, 20943, 10.1016/S0021-9258(17)31913-0 Wellen, 2010, Cellular metabolic stress: considering how cells respond to nutrient excess, Mol. Cell, 40, 323, 10.1016/j.molcel.2010.10.004 Whalen, 1991, Developmental regulation of Drosophila DNA topoisomerase II, J. Cell Biol., 112, 203, 10.1083/jcb.112.2.203 Wittmann, 2005, Dynamics of intracellular metabolites of glycolysis and TCA cycle during cell-cycle-related oscillation in Saccharomyces cerevisiae, Biotechnol. Bioeng., 89, 839, 10.1002/bit.20408 Woessner, 1991, Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerse II in NIH-3T3 cells, Cell Growth Differ., 2, 209 Wu, 2011, Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide, Science, 333, 459, 10.1126/science.1204117 Xiao, 2012, Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors, Genes Dev., 26, 1326, 10.1101/gad.191056.112 Yamagami, 2018, Cellular conditions of weakly chelated magnesium ions strongly promote RNA stability and catalysis, Nat. Commun., 9, 1, 10.1038/s41467-018-04415-1 Yan, 2009, IDH1 and IDH2 mutations in gliomas, N. Engl. J. Med., 360, 765, 10.1056/NEJMoa0808710 Yang, 2012, IDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectives, Clin. Cancer Res., 18, 5562, 10.1158/1078-0432.CCR-12-1773 Yi, 2007, Topoisomerase IIβ-mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane, Cancer Res., 67, 8839, 10.1158/0008-5472.CAN-07-1649 Zhu, 2019, Metabolic regulation of cell growth and proliferation, Nat. Rev. Mol. Cell Biol., 20, 436, 10.1038/s41580-019-0123-5